Biomatics Capital Partners, L.p. - Net Worth and Insider Trading

Biomatics Capital Partners, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Biomatics Capital Partners, L.p. owns 1 companies in total, including Verve Therapeutics Inc (VERV) .

Click here to see the complete history of Biomatics Capital Partners, L.p.’s form 4 insider trades.

Insider Ownership Summary of Biomatics Capital Partners, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
VERV	Verve Therapeutics Inc	2021-06-16	10 percent owner

Biomatics Capital Partners, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Biomatics Capital Partners, L.p. Ownership Network

Ownership Network List of Biomatics Capital Partners, L.p.

No Data

Ownership Network Relation of Biomatics Capital Partners, L.p.

Biomatics Capital Partners, L.p. Owned Company Details

What does Verve Therapeutics Inc do?

Who are the key executives at Verve Therapeutics Inc?

Biomatics Capital Partners, L.p. is the 10 percent owner of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include See Remarks Andrew D. Ashe , Chief Administrative Officer Joan Nickerson , and director & 10 percent owner Krishna Yeshwant .

Verve Therapeutics Inc (VERV) Insider Trades Summary

Over the past 18 months, Biomatics Capital Partners, L.p. made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 1,800,000 shares made by Krishna Yeshwant , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 1,514 shares made by Joan Nickerson .

In summary, during the past 3 months, insiders sold 0 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,068 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,932 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verve Therapeutics Inc Insider Transactions

No Available Data

Biomatics Capital Partners, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Biomatics Capital Partners, L.p.. You might contact Biomatics Capital Partners, L.p. via mailing address: 719 Second Avenue, Suite 1402, Seattle Wa 98104.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.